Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity
Background: Methotrexate (MTX) is an effective anticancer, anti-inflammatory, and immunomodulatory agent. However, it induces a serious pneumonitis that leads to irreversible fibrotic lung damage. This study addresses the protective role of the natural flavonoid dihydromyricetin (DHM) against MTX-in...
Main Authors: | Asmaa I. Matouk, Eman M. Awad, Nashwa F. G. El-Tahawy, Azza A. K. El-Sheikh, Aliaa Anter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/4/481 |
Similar Items
-
Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the TLR4/NF-κB pathway and NLRP3 inflammasome/caspase 1 axis
by: Asmaa I. Matouk, et al.
Published: (2022-11-01) -
Effect of vanillic acid on pentylenetetrazole-kindled rats: Nrf2/HO-1, IGF-1 signaling pathways cross talk
by: Mahmoud A. El-Hefnawy, et al.
Published: (2022-01-01) -
Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer
by: Jiajun Wu, et al.
Published: (2022-07-01) -
Dihydromyricetin Inhibits Pseudorabies Virus Multiplication In Vitro by Regulating NF-κB Signaling Pathway and Apoptosis
by: Xufan Zhao, et al.
Published: (2023-02-01) -
Dihydromyricetin Enhances Intestinal Antioxidant Capacity of Growing-Finishing Pigs by Activating ERK/Nrf2/HO-1 Signaling Pathway
by: Chuan Wei, et al.
Published: (2022-04-01)